Show/hide main menu

Publications Archive

Publications 2013



Atkinson O. Coleman T. McNeill A. Lewis S. Jones L.L. (2013). The role of nicotine replacement therapy for temporary abstinence in the home to protect children from environmental tobacco smoke exposure: a qualitative study with disadvantaged smokers. BMC Public Health.13:262.


Barrett E.L. Newton N.C. Teesson M. Slade T. Conrod P.J. (2013). Adapting the personality-targeted Preventure program to prevent substance use and associated harms among high-risk Australian adolescents. Early Intervention in Psychiatry. 1-8.  doi: 10.1111/eip.12114. [Epub ahead of print]


Beard E. Bruguera C. Brown J. McNeill A. West R. (2013). Was the expansion of the marketing license for nicotine replacement therapy in the United kingdom to include smoking reduction associated with changes in use and incidence of quit attempts?. Nicotine andTobacco Research. 15(10):1777-1781.


Bell J. (2013). Commentary on Krupitsky et al. (2013): Refuge from the streets--parked on methadone, or seeking shelter of a depot? Addiction.108(9):1638-1639.


Britton J. McNeill A. (2013). Nicotine regulation and tobacco harm reduction in the UK. Lancet. 381(9881):1879-1880.


Brose L.S. McEwen A. West R. (2013). Association between nicotine replacement therapy use in pregnancy and smoking cessation. Drug and Alcohol Dependence. 132(3):660-664.


Brose L.S. Tombor I. Shahab L. West R. (2013).The effect of reducing the threshold for carbon monoxide validation of smoking abstinence--evidence from the English Stop Smoking Services. Addictive  Behavior. 38(10):2529-2531.


Bukten A. Roislien J. Skurtveit S. Waal H. Gossop M. Clausen T (2013). A day-by-day investigation of changes in criminal convictions before and after entering and leaving opioid maintenance treatment: a national cohort study. BMC Psychiatry. 13:262.


Byford S. Barrett B, Metrebian N. Groshkova T, Cary M, Charles V, Lintzeris N, Strang J. (2013).  Cost-effectiveness of injectable opioid treatment v. oral methadone for chronic heroin addiction. British Journal of  Psychiatry. 203(5):341-349.


Carter J.L. Strang J. Frissa S. Hayes R.D. SELCoH Study Team, Hatch S.L. Hotopf M. (2013). Comparisons of polydrug use at national and inner city levels in England: associations with demographic and socioeconomic factors. Annals of Epidemiology (10):636-645.


Castonguay-Jolin L. Perrier-Ménard E. Castellanos-Ryan N. Parent S. Vitaro F. Tremblay R.E. Garel P. Séguin J.R. Conrod P.J. (2013). [SURPS French version validation in a Quebec adolescent population]. Canadian  Journal of  Psychiatry. 58(9):538-45. 


Chaar B.B. Wang H. Day C.A. Hanrahan J.R. Winstock A.R. Fois R. (2013). Factors influencing pharmacy services in opioid substitution treatment. Drug and Alcohol Review:32(4):426-434.


Corazza O. Assi S. Simonato P. Corkery J. Bersani FS. Demetrovics Z. Stair J. Fergus S. Pezzolesi C. Pasinetti M. Deluca P. Drummond C. Davey Z. Blaszko U. Moskalewicz J. Mervo B. Furia LD. Farre M. Flesland L. Pisarska A. Shapiro H. Siemann H. Skutle A. Sferrazza E. Torrens M. Sambola F. van der Kreeft P. Scherbaum N. Schifano F.(2013).  Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project. Human Psychopharmacology. 28(4):317-323.


Dockrell M. Morrison R. Bauld L. McNeill A. (2013). E-cigarettes: prevalence and attitudes in Great Britain. Nicotine and Tobacco Research. 15(10):1737-1744.


Drummond C. Strang J. (2013). Professor Griffith Edwards, CBE Obituary. Alcohol and Alcoholism. 48(1):1-3.


Gossop M. (2013). Alcohol, still the forgotten drug. Addiction. 108(7):1194-1195


Gough B. Antoniak M. Docherty G. Jones L. Stead M. McNeill A. (2013). Smoking, self-regulation and moral positioning: a focus group study with British smokers from a disadvantaged community. Psychology and Health. 28(10): 1171-1191.


Groshkova T. Metrebian N. Hallam C. Charles V. Martin A. Forzisi L. Lintzeris N. Strang J. (2013).  Treatment expectations and satisfaction of treatment-refractory opioid-dependent patients in RIOTT, the Randomised Injectable Opiate Treatment Trial, the UK's first supervised injectable maintenance clinics. Drug and Alcohol Review. 32(6):566-573.


Gunn J. Elliot P. Densley K. Middleton A. Ambresin G. Dowrick C. Herrman H. Hegarty K. Gilchrist G. Griffiths F. (2013) Taking a trajectory based approach to understand the factors associated with persistent depressive symptoms. Journal of Affective Disorders. 148(2-3): 338–346


Heinrich A. Lourdusamy A. Tzschoppe J. Vollstädt-Klein S. Bühler M. Steiner S. Bach C. Poustka L. Banaschewski T. Barker G. Büchel C. Conrod P. Garavan H. Gallinat J. Heinz A. Ittermann B. Loth E. Mann K. Martinot J.L. Paus T. Pausova Z. Smolka M. Ströhle A. Struve M. Witt S. Flor H. Schumann G. Rietschel M. Nees F. (2013). The risk variant in ODZ4 for bipolar disorder impacts on amygdala activation during reward processing. Bipolar Disorders. 15(4):440-445.


Heinrich A, Nees F, Lourdusamy A, Tzschoppe J, Meier S, Vollstädt-Klein S, Fauth-Bühler M, Steiner S, Bach C, Poustka L, Banaschewski T, Barker GJ, Büchel C, Conrod P.J. Garavan H. Gallinat J. Heinz A. Ittermann B. Loth E. Mann K. Artiges E. Paus T. Lawrence C. Pausova Z. Smolka M.N. Ströhle A. Struve M.Witt S.H. Schumann G. Flor H. Rietschel M.; IMAGEN consortium (2013). From gene to brain to behavior: schizophrenia-associated variation in AMBRA1 alters impulsivity-related traits. European Journal of Neuroscience. 38(6):2941-2945.


Hines L.A. Jawahar K. Wessely S. Fear N. (2013) Self-harm in the UK military. Occupational Medicine. 63(5):354-357.


Hiscock R. Murray S. Brose L.S. McEwen A. Bee J.L. Dobbie F. Bauld L. (2013). Behavioural therapy for smoking cessation: the effectiveness of different intervention types for disadvantaged and affluent smokers. Addictive Behaviors. 38(11):2787-2796.


Jawad M. McEwen A. McNeill A. Shahab L. (2013). The importance of addressing waterpipe tobacco smoking: research and policy responses. Addiction. 108(11):1887-1888.


Jawad M. McEwen A. McNeill A. Shahab L. (2013). To what extent should waterpipe tobacco smoking become a public health priority? Addiction. 108(11):1873-1884.


Kapitány-Fövény M. Kertész M. Winstock A. Deluca P. Corazza O. Farkas J. Zacher G. Urbán R. Demetrovics Z. (2013). Substitutional potential of mephedrone: an analysis of the subjective effects. Human Psychopharmacology. 28(4):308-16


Langley T. Lewis S. McNeill A. Gilmore A. Szatkowski L. West R. Sims M. (2013). Characterizing tobacco control mass media campaigns in England. Addiction. 108(11):2001-2008.


Lee C.T. Chen V.C. Tan H.K. Chou S.Y. Wu K.H. Chan C.H. Gossop M. (2013). Suicide and other-cause mortality among heroin users in Taiwan: a prospective study. Addictive Behaviors. 38(10):2619-2623.


Lee N.C. Krabbendam L. White T.P. Meeter M. Banaschewski T. Barker G.J. Bokde A.L. Büchel C. Conrod P. Flor H. Frouin V. Heinz A. Garavan H. Gowland P. Ittermann B. Mann K. Paillère Martinot M.L. Nees F, Paus T, Pausova Z, Rietschel M, Robbins T, Fauth-Bühler M, Smolka MN, Gallinat J. Schumann G. Shergill S.S. (2013). Do you see what I see? Sex differences in the discrimination of facial emotions during adolescence. Emotion.13(6):1030-1040.


Lin T.Y. Chen V.C. Lee C.H. Chen C.Y. Shao W.C. Chang S.H. Chou J.Y. Lai T.J. Ferri C.P. Gossop M. Lee C.T. (2013). Prevalence, correlates, and risk perception of HIV infection among heroin users in Central Taiwan. Kaohsiung Journal of Medical Sciences. 29(12):673-679.


Lynskey M. (2013). Vulnerability for psychosis at ages 13 and 16 predicts cannabis use at ages 16 and 19, and cannabis use at age 16 predicts psychosis vulnerability at age 19. Evidence-Based Mental Health. 16(4):99.


Lynskey M.T. Strang J. (2013). The global burden of drug use and mental disorders. Lancet. 382(9904):1540-1542.


Marlow S.  (2013). It’s different for girls. Druglink. July/August issue pp 8 - 9

Marlow S & Drummond C. (2013). Keeping it in the Family. Alcoholism: Clinical & Experimental Research 37 (S2) p 87a. 


Marlow S.  (2013). I worry when: insights into dual diagnosis from those who treat mothers misusing alcohol.  Advances in Dual Diagnosis 7 (1) pp 1- 10


Marlow S. Campbell J. & Drummond C. (2014).  Maternal drinking and parenting capacity: Why do some mothers who misuse alcohol lose their children when others do not? Family Law. June issue.


McDermott MS. Beard E. Brose LS. West R. McEwen A. (2013). Factors associated with differences in quit rates between "specialist" and "community" stop-smoking practitioners in the English stop-smoking services. Nicotine & Tobacco Research. 15(7):1239-47


Montigny C. Castellanos-Ryan N. Whelan R. Banaschewski T. Barker GJ. Büchel C. Gallinat J. Flor H. Mann K. Paillère-Martinot ML. Nees F. Lathrop M. Loth E. Paus T. Pausova Z. Rietschel M. Schumann G. Smolka MN. Struve M. Robbins TW. Garavan H. Conrod PJ; IMAGEN Consortium (2013). A phenotypic structure and neural correlates of compulsive behaviors in adolescents. PLoS One. 2013 Nov 14;8(11):e80151. doi: 10.1371/journal.pone.0080151.


Morley KC. Baillie A. Sannibale C. Teesson M. Haber PS. (2013). Integrated care for comorbid alcohol dependence and anxiety and/or depressive disorder: study protocol for an assessor-blind, randomized controlled trial. Addiction Science & Clinical Practice 19;8(1):19.


Morley KC. Leung S. Baillie A. Haber PS.(2013). The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial. Contemporary Clinical Trials 36(2):348-55.


Neale J. (2013). Commentary on "Substitution treatment in the era of 'recovery': an analysis of stakeholder roles and policy windows in Britain". Substance Use & Misuse. 48(11):1059-60


Neale J. (2013). Opioid pharmacotherapy: Treatment, regimes, constructions and control. International Journal of Drug Policy. (6):e1-5.


Neale J. and Stevenson C. (2013). A qualitative exploration of the spatial needs of homeless drug users living in hostels and night shelters. Social Policy and Society 12, 533-546.


Neale J. (2013). Commentary on “Substitution treatment in the era of recovery: an analysis of stakeholder roles and policy windows in Britain”. Substance Use and Misuse 48, 1059-1060.


Neale J. Nettleton S. and Pickering L. (2013). Does recovery-oriented treatment prompt heroin users prematurely into detoxification and abstinence programmes? Qualitative study. Drug and Alcohol Dependence 127, 163-169.


Neale J. Hunt G. Lankenau S. Mayock P. Miller P. Sheridan J. Small W. and Treloar C. (2013) Addiction journal is committed to publishing qualitative research. Addiction 108, 447-449.


Nees F. Witt SH. Lourdusamy A. Vollstädt-Klein S. Steiner S. Poustka L. Banaschewski T. Barker GJ. Büchel C. Conrod PJ. Frank J. Gallinat J. Garavan H. Heinz A. Ittermann B. Loth E. Mann K. Artiges E. Paus T. Pausova Z. Smolka MN. Struve M. Schumann G. Rietschel M. Flor H. IMAGEN consortium. (2013). Genetic risk for nicotine dependence in the cholinergic system and activation of the brain reward system in healthy adolescents.  Neuropsychopharmacology ;38(11):2081-9


Nettleton S. Neale J. and Pickering L. (2013). ”I just want to be normal”: an analysis of discourses of normality among recovering heroin users. Health: An Interdisciplinary Journal for the Study of Health, Illness and Medicine 17, 174-190.


Nymberg C. Jia T. Lubbe S. Ruggeri B. Desrivieres S. Barker G. Büchel C. Fauth-Buehler M. Cattrell A. Conrod P. Flor H. Gallinat J. Garavan H. Heinz A. Ittermann B. Lawrence C. Mann K. Nees F. Salatino-Oliveira A. Paillère Martinot ML. Paus T. Rietschel M. Robbins T. Smolka M. Banaschewski T. Rubia K. Loth E. Schumann G. IMAGEN Consortium. (2013). Neural mechanisms of attention-deficit/hyperactivity disorder symptoms are stratified by MAOA genotype.  Biological Psychiatry. 74(8):607-14


O'Leary-Barrett M. Topper L. Al-Khudhairy N. Pihl RO. Castellanos-Ryan N. Mackie CJ. Conrod PJ. (2013). Two-year impact of personality-targeted, teacher-delivered interventions on youth internalizing and externalizing problems: a cluster-randomized trial. Journal of the American Academy of Child & Adolescent Psychiatry. 52(9):911-20. doi: 10.1016/j.jaac.2013.05.020.


Opaleye ES. Noto AR. Sanchez ZM. Amato TC. Locatelli DP. Gossop M. Ferri CP. (2013). Nonprescribed use of tranquilizers or sedatives by adolescents: a Brazilian national survey.  BMC Public Health. 13:499.


Pickering L. Neale J. and Nettleton S. (2013). Recovering a fecal habitus: analysing heroin users’ toilet talk. Medical Anthropology 32, 95-108.


Pine-Abata H. McNeill A. Murray R. Bitton A. Rigotti N. Raw M. (2013). A survey of tobacco dependence treatment guidelines in 121 countries. Addiction. 2013 Aug 108(8):1470-5. doi: 10.1111/add.12158. Epub 2013 Apr 22.


Piné-Abata H. McNeill A. Murray R. Bitton A. Rigotti N. Raw M. A survey of tobacco dependence treatment services in 121 countries. Addiction. 2013 Aug 108(8):1476-84. doi: 10.1111/add.12172. Epub 2013 Apr 10.


Rooke C. McNeill A. Arnott D. (2013). Regulatory issues concerning the development and circulation of nicotine-containing products: a qualitative study.  Nicotine & Tobacco Research. 15(6):1052-9.


Sartor CE. Nelson EC. Lynskey MT. Madden PA. Heath AC. Bucholz KK. (2013). Are there differences between young African-American and European-American women in the relative influences of genetics versus environment on age at first drink and problem alcohol use?. Alcoholism: Clinical & Experimental Research. 37(11):1939-46.


Shahab L. Brose LS. West R. (2013). Novel delivery systems for nicotine replacement therapy as an aid to smoking cessation and for harm reduction: rationale, and evidence for advantages over existing systems.  CNS Drugs (12):1007-19


Shiles CJ. Canning UP. Kennell-Webb SA. Gunstone CM. Marshall EJ. Peters TJ. Wessely SC. (2013). Randomised controlled trial of a brief alcohol intervention in a general hospital setting. Trials. 14:345.


Skeie I. Brekke M. Clausen T. Gossop M. Lindbaek M. Reinertsen E. Thoresen M. Waal H. (2013). Increased somatic morbidity in the first year after leaving opioid maintenance treatment: results from a Norwegian cohort study.  European Addiction Research. 19(4):194-201, 2013.


Stapleton J. West R. Hajek P. Wheeler J. Vangeli E. Abdi Z. O'Gara C. McRobbie H. Humphrey K. Ali R. Strang J. Sutherland G. (2013). Randomized trial of nicotine replacement therapy (NRT), bupropion and NRT plus bupropion for smoking cessation: effectiveness in clinical practice.  Addiction.108(12):2193-201.


Stead M. Jones L. Docherty G. Gough B. Antoniak M. McNeill A. (2013). 'No-one actually goes to a shop and buys them do they?': attitudes and behaviours regarding illicit tobacco in a multiply disadvantaged community in England.  Addiction. 108(12):2212-9.


Stead M. Moodie C. Angus K. Bauld L. McNeill A. Thomas J. Hastings G. Hinds K. O'Mara-Eves A. Kwan I. Purves RIRI. Bryce SL. (2013). Is consumer response to plain/standardised tobacco packaging consistent with framework convention on tobacco control guidelines? A systematic review of quantitative studies.  PLoS ONE [Electronic Resource]. 8(10):e75919.


Strang J. Bird SM. Parmar MK. (2013). Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial.  Journal of Urban Health. 2013 Oct. 90(5):983-96.


Szatkowski L. McNeill A. (2013). The delivery of smoking cessation interventions to primary care patients with mental health problems. Addiction. 108(8):1487-94


Thomson A.D. Marshall E.J.(2013). BNF recommendations for the treatment of Wernicke's encephalopathy: lost in translation?  Alcohol Alcohol. 2013 Jul-Aug; 48(4):514-5


Verweij K. J. H. Agrawal A. Nat N.O. Creemers H.E. A. C. Huizink N. G. Martin and M. T. Lynskey (2013). A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5. A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5.  Psychological Medicine. Volume  43, Issue 08, August 2013, pp 1713 - 1722


Verweij K.J. Huizink A.C. Agrawal A. Martin N.G. Lynskey M.T. (2013). Is the relationship between early-onset cannabis use and educational attainment causal or due to common liability?. Drug & Alcohol Dependence. 133(2):580-6, 2013 Dec 1.


Verweij K.J. Vinkhuyzen A.A. Benyamin B. Lynskey M.T. Quaye L. Agrawal A. Gordon S.D. Montgomery G.W. Madden P.A. Heath A.C. Spector T.D. Martin N.G. Medland S.E. (2013). The genetic aetiology of cannabis use initiation: a meta-analysis of genome-wide association studies and a SNP-based heritability estimation. Addiction Biology. 18(5):846-850.


Williams A.V. Strang J. Marsden J. (2013). Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation.  Drug and Alcohol Dependence. 132(1-2):383-6.


Winstock A.R. Barratt M.J. (2013). Synthetic cannabis: a comparison of patterns of use and effect profile with natural cannabis in a large global sample. Drug and Alcohol Dependence. 131(1-2):106-111.


Winstock A. Bell J. Borschmann R. (2013). Friends, doctors, and tramadol: we might have a problem.  BMJ. 347: f5599. doi: 10.1136/bmj.f5599


Winstock A.R. Barratt MJ. (2013). The 12-month prevalence and nature of adverse experiences resulting in emergency medical presentations associated with the use of synthetic cannabinoid products.  Human Psychopharmacology. 28(4):390-3. doi: 10.1002/hup.2292.


Wu CY. Chang CK. Robson D. Jackson R. Chen SJ. Hayes RD. Stewart R. (2013). Evaluation of smoking status identification using electronic health records and open-text information in a large mental health case register. PLoS One. 8(9):e74262. doi: 10.1371/journal.pone.0074262.

Sitemap Site help Terms and conditions  Privacy policy  Accessibility  Modern slavery statement  Contact us

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454